KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology (VIR) has disclosed Current Taxes for 3 consecutive years, with $15.3 million as the latest value for Q1 2023.

  • Quarterly Current Taxes fell 96.23% to $15.3 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Mar 2023, down 96.23% year-over-year, with the annual reading at $15.2 million for FY2022, 144.94% up from the prior year.
  • Current Taxes hit $15.3 million in Q1 2023 for Vir Biotechnology, roughly flat from $15.2 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $404.4 million in Q1 2022 to a low of $6.2 million in Q4 2021.
  • Historically, Current Taxes has averaged $116.1 million across 3 years, with a median of $56.7 million in 2022.
  • Biggest five-year swings in Current Taxes: skyrocketed 144.94% in 2022 and later crashed 96.23% in 2023.
  • Year by year, Current Taxes stood at $6.2 million in 2021, then skyrocketed by 144.94% to $15.2 million in 2022, then grew by 0.16% to $15.3 million in 2023.
  • Business Quant data shows Current Taxes for VIR at $15.3 million in Q1 2023, $15.2 million in Q4 2022, and $98.2 million in Q3 2022.